Material Weakness (removed) — Material weaknesses in internal controls (insufficient accounting personnel, deficient risk assessment, inadequate IT controls, missing formal policies) disclosed in baseline filing but entire controls section absent from current filing.

NASDAQ: COCHW Envoy Medical, Inc. 10-Q

Envoy completes 56-patient trial enrollment, raises $27.6M; material weakness disclosures vanish

Filed May 11, 2026 · Period ending March 31, 2026 · Compared to 10-Q May 1, 2025 · ~1 min read

5 material changes detected in this filing.

Create a free account to read the full summary — it takes 30 seconds.

Partner

Trade COCHW commission-free

Open an account, get a free stock.

Investing involves risk. Free stock terms apply.

Generated by AI · Jun 1, 2026 7:29 PM